Glimisave MV 1 Tablet SR
Glimisave MV 1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹171
that's 84% off!
About This Medicine
Product description & overview
Glimisave MV 1 Tablet SR: A Combined Approach to Blood Sugar Control
Glimisave MV 1 Tablet SR is a unique medication formulated with three key ingredients: Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg). This tablet effectively aids in managing blood sugar levels by targeting different mechanisms of action.
Glimepiride: This sulfonylurea stimulates insulin secretion from the pancreas, helping to lower blood glucose levels.
Metformin: A first-line choice for Type 2 diabetes, it reduces hepatic glucose production and improves insulin sensitivity.
Voglibose: This alpha-glucosidase inhibitor slows down the absorption of sugars in the small intestine, further contributing to reduced postprandial hyperglycemia (high blood sugar after meals).
Glimisave MV 1 Tablet SR is a convenient combination therapy for individuals with Type 2 diabetes seeking effective and comprehensive blood sugar control. Always consult your physician before starting or discontinuing any medication.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glimepiride
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimisave MV 1 Tablet SR.
High Risk
Pregnancy
Glimisave MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimisave MV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimisave MV 1 Tablet SR may be needed. Please consult your doctor. Glimisave MV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimisave MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimisave MV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimisave MV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glimisave MV 1 Tablet SR